ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Arthritis"

  • Abstract Number: 1033 • ACR Convergence 2021

    Physical Inactivity Among Adults with Specific Chronic Conditions, by Arthritis Status, 49 States and District of Columbia, Behavioral Risk Factor Surveillance System, 2019

    Dana Guglielmo1, Charles Helmick2, Michael Boring3, Kristina Theis2, Louise Murphy4, Kathleen Watson2, Lisa McGuire2 and Lindsey Duca5, 1Student, Atlanta, GA, 2Centers for Disease Control and Prevention, Atlanta, GA, 3ASRT Inc., Atlanta, GA, 4Optum Life Sciences, Inc., Eden Prairie, MN, 5Centers for Disease Control, Atlanta, GA

    Background/Purpose: Arthritis is associated with reduced physical activity (PA). PA can improve functional status, brain health, and weight management, reduce pain, prevent chronic disease, falls,…
  • Abstract Number: 0532 • ACR Convergence 2020

    State-Specific Percentage of Adults with Arthritis Who Report Both Severe Joint Pain and Physical Inactivity and Their Characteristics, United States, Behavioral Risk Factor Surveillance System, 2017

    Dana Guglielmo1, Louise Murphy1, Jennifer Hootman1, Michael Boring1, Kristina Theis1, Charles Helmick1, Susan Carlson1, Yong Liu1, Hua Lu1 and Janet Croft1, 1Centers for Disease Control and Prevention, Atlanta, GA

    Background/Purpose: About one in four (27%) US adults with arthritis have severe joint pain, and only 36% meet the Physical Activity Guidelines for Americans. While…
  • Abstract Number: 046 • 2020 Pediatric Rheumatology Symposium

    Near Infrared Indocyanine Green Imaging Reveals Altered Anatomy and Diminished Function in Lymphatic Vessels in the Hands of Rheumatoid Arthritis Patients During Flare

    Richard Bell 1, Homaira Rahimi2, H. Mark Kenney 2, Ronald Wood 2, Alicia Lieberman 3, Edward Schwarz 4 and Christopher Ritchlin 5, 1University of Rochester Medical Center, Rochester, 2University of Rochester, Rochester, 3Batavia, 4University of Rochester, Rochester, NY, USA, Rochester, 5University of Rochester Medical Center, Canandaigua

    Background/Purpose: Near infrared (NIR) imaging studies of subdermal indocyanine green (ICG) in murine models of inflammatory arthritis have established abnormal lymphatic vessel (LV) function during…
  • Abstract Number: 067 • 2020 Pediatric Rheumatology Symposium

    Response to Treatment with Intra-articular Triamcinolone Hexacetonide and Triamcinolone Acetonide in Oligo-articular Juvenile Idiopathic Arthritis

    Rana Masoud1, Wajiha Jeelani 2, Barbine Agbor Agbor 3, Teresa Hennon 2, Brian Wrotniak 4 and Rabheh Abdul Aziz 2, 1Department of Pediatrics, University at Buffalo, Oishei Children's Hospital, Buffalo, New York, 2Department of Pediatric Rheumatology, University at Buffalo, Oishei Children's Hospital, Buffalo, 3Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, Buffalo, 4Department of Pediatrics, University at Buffalo, Oishei Children's Hospital, Buffalo, NY, USA, Buffalo

    Background/Purpose: Oligo-articular juvenile idiopathic arthritis (Oligo JIA) is the most common subtype of juvenile idiopathic arthritis. Intra-articular corticosteroid (IAC) injection is a mainstay treatment of…
  • Abstract Number: 089 • 2020 Pediatric Rheumatology Symposium

    Associations Among Pain, Mood, and Sleep in Children with Rheumatic Conditions

    Arionna Rudolph1, Kathryn Thompson 1, Aaron Fobian 1, Matthew Stoll 1, Peter Weiser 2 and Burel Goodin 1, 1University of Alabama at Birmingham, Birmingham, 2Birmingham

    Background/Purpose: Chronic pain in school-aged children and adolescents is highly prevalent and can be debilitating. Literature suggests that children with musculoskeletal pain are at risk…
  • Abstract Number: 114 • 2020 Pediatric Rheumatology Symposium

    Musculoskeletal Ultrasound Study in Childhood Arthritis: A Limited Examination

    Patricia Vega-Fernandez1, Tracy Ting 1, Edward Oberle 2, Janet Figueroa 3, Courtney McCracken 4 and Johannes Roth 5, 1Cincinnati Children's Hospital Medical Center, Cincinnati, 2Division of Rheumatology, Nationwide Children's Hospital, Columbus, 3Emory University, Atlanta, 4Emory University School of Medicine, Atlanta, 5Division of Pediatric Rheumatology, Children Hospital of Eastern Ontario, Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada

    Background/Purpose: A challenge in the management of Juvenile Idiopathic Arthritis (JIA) is most of the core set of assessment measurements are subjective by nature.  A…
  • Abstract Number: 1771 • 2019 ACR/ARP Annual Meeting

    MyD88 S209R Enhances Inflammation in Mouse Models of Arthritis

    Sufia Bakshi1, Anders Lindstedt 2, Malika Waschmann 3, Wanxia Tsai 1, Robert Colbert 4 and Keith Sikora 1, 1National Institutes of Health, Bethesda, MD, 2NIH, Bethesda, MD, 3Oregon Health and Science University, Portland, OR, 4Pediatric Clinical Trials Unit, Pediatric Translational Research Branch, NIAMS, NIH, Bethesda, MD

    Background/Purpose: MyD88 is a critical adaptor protein that connects Toll-like and IL-1 receptor signaling to activation of NF-kB. We previously reported a heterozygous de novo gain-of-function mutation in MYD88 (S222R)…
  • Abstract Number: 2062 • 2019 ACR/ARP Annual Meeting

    Arthritis, Physical Function, and Disability Among Older Mexican Americans over 20-Years of Follow-up

    Martin A Rodriguez1, Lin-Na Chou 1, Jaspreet K Sodhi 1, Kyriakos S Markides 1, Kenneth J Ottenbacher 1 and Soham Al Snih 1, 1The University of Texas Medical Branch, Galveston

    Background/Purpose: Hispanics are the fastest growing group of older adults in the US, with older Mexican Americans the largest segment of US Hispanics (65%), a…
  • Abstract Number: 2063 • 2019 ACR/ARP Annual Meeting

    Arthritis, Upper-Lower Extremity Functional Limitations, and Disability in American Older Adults: Findings from the National Health and Aging Trends Study (NHATS)

    Martin A Rodriguez1, Jaspreet K Sodhi 1 and Soham Al Snih 1, 1The University of Texas Medical Branch, Galveston

    Background/Purpose: To examine the effect of arthritis on upper-lower extremity (UE-LE) functional limitations and disability over 6-years of follow-up among American older adults.Methods: Data are…
  • Abstract Number: 2119 • 2019 ACR/ARP Annual Meeting

    Impact of Day of Admission and Time to Diagnostic Arthrocentesis on Mortality and Other Outcomes in Septic Arthritis: A Nationwide Analysis

    Gustavo Contreras1, Ana B Arevalo 1, Shane Murray 1, Faris Haddadin 1 and Yiming Luo 1, 1Mount Sinai St. Luke's - West/ Icahn School of Medicine, New York, NY

    Background/Purpose: Multiple studies have been done assessing the “weekend effect” and outcomes for hospitalized patients 1,2,3,4, however, there is no data evaluating the outcome of…
  • Abstract Number: 2130 • 2019 ACR/ARP Annual Meeting

    Enrichment of IL-17-producing CD4+ T Cells in Synovial Fluid from Patients with Arthritis After anti-CTLA-4 and anti-PD-1 Combination Therapy

    Sang Kim1, Jean Tayar 1, Maria E. Suárez-Almazor 2, Huifang Lu 1, Yang-Zhi Zhao 1, Zhongshan Liu 3, Emma Rodriguez 1, Sattva Neelapu 1, Jennifer Wang 1, Amishi Shah 1, Nizar Tannir 3, Don Gibbons 3, Guillermo Garcia-Manero 3, Hussein Tawbi 3, Patrick Hwu 1, Andrew Futreal 3, Adi Diab 3 and Roza Nurieva 3, 1MD Anderson Cancer Center, Houston, TX, 2Department of Rheumatology/Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX , USA., Houston, TX, 3MD Anderson Cancer Center, Houston

    Background/Purpose: Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs), including arthritis (arthritis-irAE). Understanding the pathophysiology of arthritis-irAE is critical to treating it…
  • Abstract Number: 56 • 2019 ACR/ARP Annual Meeting

    Choline Metabolite Is Associated with Inflammation in Arthritis in the Elderly

    francesca cedola1, Roxana Coras 2, Elsa Sanchez-Lopez 3, Lourdes Mateo 4, Anders Pedersen 5, Anahy Brandy-Garcia 4, Águeda Prior-Español 4, Brin S rosenthal 6, Melania Martínez-Morillo 4 and Monica Guma 7, 1University of California San Diego, Rome, Italy, 2. Department of Medicine, School of Medicine. University of California, San Diego, 3Department of Pharmacology, University of California San Diego, La Jolla, San Diego, 4Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 5University of Gothenburg, Gothenburg, Sweden, 6University of California San Diego, san diego, 7Department of Medicine, School of Medicine. University of California San Diego, La Jolla, United States

    Background/Purpose: Elderly-onset RA (EORA) and polymyalgia rheumatica (PMR) are common rheumatic disease in the elderly and their pathogenesis are still not completely understood. Perturbations caused…
  • Abstract Number: 2139 • 2019 ACR/ARP Annual Meeting

    Rheumatic Immune-Related Adverse Events Associated with Treatment with Immune Checkpoint Inhibitors: A Multicenter Study of 38 Cases

    Sebastian Rodriguez-Garcia1, David Lobo 2, Fabiola Ojeda 3, Raul Castellanos-Moreira 4, Ana Laiz 2, Roberto Gumucio 4, Cesar Diaz-Torné 2, Virginia Ruiz-Esquide 5, Milena Millan 2, Ivan Castellvi 6, Patricia Moya Alvarado 7, Berta Magallares 2, Carolina Perez 3, Hector Corominas 8 and Jose Gomez-Puerta 9, 1Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Spain, 2Rheumatology Department. Hospital Sant Pau, Barcelona, Catalonia, Spain, 3Rheumatology Department. Hospital del Mar, Barcelona, Catalonia, Spain, 4Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain, 5Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, 6Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 7Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain, 8Rheumatology Department, Hospital Sant Pau, Barcelona, Catalonia, Spain, 9Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Spain

    Background/Purpose: Immune checkpoint inhibitors (ICI) against CTLA-4 or PD- 1/PD-L1 and more recently TIM3,  have demonstrated efficacy in improving the survival of patients with diverse…
  • Abstract Number: 99 • 2019 ACR/ARP Annual Meeting

    Mass Cytometry Immunophenotyping of Synovial Fluid from Checkpoint Inhibitor Related Arthritis

    Runci Wang1, Karmela Kim Chan 2, Amy Cunningham-Bussel 3, Laura Donlin 4, Gregory Vitone 2, Aidan Tirpack 2, Caroline Benson 2, Gregory Keras 3, Anna Helena Jonsson 5, Michael Brenner 6, Anne Bass 7 and Deepak Rao 1, 1Brigham and women's hospital, Boston, MA, 2Hospital For Special Surgery, New York, 3Brigham and women's hospital, Boston, 4Hospital For Special Surgery, New York, NY, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 6Brigham and Women’s Hospital:, Boston, 7Hospital for Special Surgery/Weill Cornell Medicine, New York, NY

    Background/Purpose: Anti-PD-1/PD-L1 checkpoint inhibitor therapies have produced remarkable results in stimulating immune responses against tumors. Checkpoint inhibitor therapy can also trigger a variety of autoimmune…
  • Abstract Number: 2157 • 2019 ACR/ARP Annual Meeting

    Checkpoint Inhibitor-Associated Arthritis: Phenotype, Steroid Dose, Serology and Survival

    Karmela Kim Chan 1, Aidan Tirpack 1, Caroline Benson 1, Gregory Vitone 1, Jackie Finik 2, Vivian Bykerk 3, Susan Goodman 4, Laura Donlin 5, Deepak Rao 6 and Anne Bass4, 1Hospital For Special Surgery, New York, 2Hospital for Special Surgery, New York, NY, New York, NY, 3Hospital for Special Surgery, New York City, NY, 4Hospital For Special Surgery/Weill Cornell Medicine, New York, NY, 5Hospital For Special Surgery, New York, NY, 6Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Previous studies suggest that steroid dose1and rheumatoid factor positivity2 impact cancer survival in checkpoint inhibitor (CI)-treated patients (with CI-associated hypophysitis, and in all-comers with non-small…
  • 1
  • 2
  • 3
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology